Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 10Terminated 3Completed 3Active not recruiting 3Unknown 1Suspended 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other 3Gastrointestinal 3Other hematologic neoplasm 1Lymphoid 1

Conditions

Colorectal Neoplasms 307Pancreatic Neoplasms 206Stomach Neoplasms 162Carcinoma, Hepatocellular 160Colonic Neoplasms 115Rectal Neoplasms 104Esophageal Neoplasms 91Carcinoma, Non-Small-Cell Lung 91Breast Neoplasms 76Neoplasms 67Liver Neoplasms 62Ovarian Neoplasms 60Melanoma 51Neoplasm Metastasis 50Cholangiocarcinoma 49Lung Neoplasms 48Squamous Cell Carcinoma of Head and Neck 37Esophageal Squamous Cell Carcinoma 37Gastrointestinal Neoplasms 36Carcinoma, Renal Cell 35Prostatic Neoplasms 33Uterine Cervical Neoplasms 32Sarcoma 32Endometrial Neoplasms 32Biliary Tract Neoplasms 31Anus Neoplasms 30Head and Neck Neoplasms 27Urinary Bladder Neoplasms 22Triple Negative Breast Neoplasms 21Adenocarcinoma Of Esophagus 21

Interventions

Specimen Handling 1Magnetic Resonance Spectroscopy 1Lisinopril 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Non-alcoholic Fatty Liver Disease × Gastrointestinal × Clear all
NCT04550481 2026-01-21

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

Northwestern University

Phase 2 Active not recruiting
45 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Non-alcoholic Fatty Liver Disease

NCT06842563 2025-07-09

Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial

Singlera Genomics Inc.

Active not recruiting
900 enrolled
Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease

NCT06315361 2024-03-18

DIANA

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Active not recruiting
600 enrolled
Gastrointestinal

Diabetes Mellitus, Fibrosis, Liver Cirrhosis, Liver Neoplasms, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡